Miltenyi Biotec B.V. & Co. KG
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
16
Ending by 2030
Mar 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 4 fees due Jan 2 to 18, 2027 · next Jan 2
- 2 fees due Mar 15 to 26, 2027 · next Mar 15
- 1 fee due May 26, 2027The maintenance fee for Refillable column system (US 10,486,165) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
- 1 fee due Jun 24, 2027The maintenance fee for Method for polyclonal stimulation of T cells by flexible nanomatrices (US 10,513,687) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.
- 2 fees due Jul 9 to 30, 2027 · next Jul 9
- 1 fee due Aug 6, 2027The maintenance fee for Immune Cells Expressing an Antigen Binding Receptor and a Chimeric Costimulatory Receptor (US 11,890,300) comes due Aug 6, 2027. Unpaid by Feb 7, 2028, it lapses early.
- 1 fee due Sep 19, 2027The maintenance fee for Devices and Disposables for Patient-Specific Cell Therapy Manufacturing (US 11,933,787) comes due Sep 19, 2027. Unpaid by Mar 20, 2028, it lapses early.
- 3 fees due Oct 14 to 16, 2027 · next Oct 14
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
- Sep 15 US 12,735,450 Serum Resistant Bis-Sulfhydryl Specific Biotinylation Reagent
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,839,450 | Image sensor device, apparatus and method for optical measurements In force · USPTO record | In force | USPTO record | |
| US 9,625,463 | System for Separating a Cell Sample by Centrifugation and Column Chromatography While Maintaining Sterility In force · High confidence | In force | High confidence | |
| US 10,119,970 | Self-Contained Disposable Tubing Set for Sterile Preparation of Cells by Culturing, Centrifugation, and Column Chromatography In force · High confidence | In force | High confidence | |
| US 10,620,212 | Preparing Antigen-Specific T Cells Using a Self-Enclosed Processing System That Contains Both a Centrifuge and a Magnetic Separation Column In force · High confidence | In force | High confidence | |
| US 10,705,090 | Automated Method for Sterile Processing of Cells by Centrifugation and Column Chromatography In force · High confidence | In force | High confidence | |
| US 10,705,091 | Preparing Genetically Modified Cells Using a Device That Is Configured for Sterile Processing of Cells at the Bedside or in a Surgical Room In force · High confidence | In force | High confidence | |
| US 11,499,976 | Device and Procedure for Producing a Cellular Pharmaceutical Product Enriched in Genetically Modified Target Cells at the Bedside or in a Surgical Room In force · High confidence | In force | High confidence | |
| US 11,499,977 | Equipment and procedure for culturing, separating, and genetically modifying donor cells for reinfusion into a patient In force · High confidence | In force | High confidence | |
| US 11,531,031 | Single use tubing set for making genetically modified donor cells for reinfusion into a patient In force · High confidence | In force | High confidence | |
| US 11,933,787 | Devices and Disposables for Patient-Specific Cell Therapy Manufacturing In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 106: 2 patents in force now held by others · 8 lapsed for an unpaid fee · 12 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
28 pending · 8 abandoned · 21 no status recorded